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ª 2013 by the American College of Cardiology FoundationReal-time myocardial contrast echocardiography (RTMCE)
is a technique that allows for the simultaneous analysis of
myocardial perfusion and wall motion during stress echo-
cardiography (1–3). Retrospective studies have shown that
myocardial perfusion data obtained with RTMCE may be
incremental to wall motion analysis in detecting coronary
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13; revised manuscript received April 11, 2013,the test (4–8). However, these studies may have been
hampered by selection bias, and the inability to accurately
determine what effect a normal or abnormal study has on
subsequent revascularization rate. There have been no
prospective randomized studies to date examining the effect
of 1 stress imaging modality versus another in predicting
patient outcome. Therefore, in this study, we prospectively
compared RTMCE to conventional stress echocardiog-
raphy (CSE) in patients presenting for suspicion of CAD,
to determine whether the differences in test performance
for detecting CAD lead to differences in the rate of angi-
ography and revascularization, as well as predicting death or
nonfatal myocardial infarction (MI). Secondly, we deter-
mined what effect training experience with contrast
imaging had on the predictive value of either CSE or
RTMCE.
Abbreviations
and Acronyms
CAD = coronary artery
disease
CSE = conventional stress
echocardiography
DSE = dobutamine stress
echocardiography
EFS = event-free survival
MI = myocardial infarction
RTMCE = real-time
myocardial contrast
echocardiography
WM = wall motion
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Study population. Consecutive patients referred to the
echocardiography laboratory at the University of Nebraska
Medical Center between 2007 and 2011 were asked to
participate in the study if they were considered to have
intermediate to high pre-test probability for CAD, and
scored between 7 and 9 for appropriateness indications for
stress echocardiography (9). This included both outpatient
and inpatient subjects who were admitted for chest pain or
shortness of breath with normal or equivocal troponin
values. Exclusion criteria included those with known
hypersensitivity to contrast agents, low pre-test probability
of CAD, pregnancy or breastfeeding, or ventricular paced
rhythm. All patients gave written informed consent, and the
study protocol was approved by the University of Nebraska
Medical Center Institutional Review Board. Those who
consented to participate in the study were randomized,
using an internet-based site, to undergo either CSE or
RTMCE as their imaging technique (NCT00575549).
A total of 4 experienced stress echo readers who had Level
III training in the performance and interpretation of echo-
cardiography using 2008 COCATS (Core Cardiology
Training Symposium) guidelines (10), and who had inter-
preted over 100 CSE and RTMCE studies with contrast,
served as 1 group of reviewers (R2), and were compared with
a Level III echo-trained physician who had interpreted over
1,000 contrast studies (R1). All interpreting physicians had
access to clinical indications, and were aware of patient risk
factors at the time of their interpretations.
Imaging techniques with contrast. The contrast agent
used for the study was the commercially available lipid
encapsulated microbubble, Deﬁnity (Lantheus Medical
Imaging, North Billerica, Massachusetts). This agent was
administered as a 3% intravenous continuous infusion at
4 to 6 ml/min under resting conditions and during stress.
RTMCE was performed using ultrasound scanners equipped
with low-mechanical index real-time pulse sequence
schemes (4–8). This utilized a mechanical index of <0.2,
frame rates of 20 to 25 Hz, time gain compensation higher in
the near ﬁeld, focus at the mitral valve plane or below, and
overall gain settings adjusted so that brief high mechanical
index impulses clear the myocardial segments of any signals.
For CSE, Deﬁnity contrast was administered only when 2
contiguous segments could not be visualized, as recom-
mended by the 2008 American Society of Echocardiography
guidelines (8).
The decision to perform dobutamine or exercise treadmill
stress echocardiography was made by the referring physician.
In either case, patients were instructed to discontinue beta-
blocker drugs at least 24 h prior to the stress test. Patients
undergoing treadmill stress underwent maximal symptom-
limited exercise according to the Bruce protocol. Patients
undergoing dobutamine stress echocardiography (DSE)
received intravenous dobutamine infusion at a starting dose
of 5 m/kg/min, followed by increasing doses of 10, 20, 30,40, up to a maximal dose of 50
m/kg/min, in 3- to 5-min stages.
Atropine (up to 2.0 mg) was
injected in patients not achieving
85% of the predicted maximal
heart rate. Subsequent angiograms
and revascularizations (percuta-
neous coronary interventions or
coronary bypass surgery) were
performed if clinically indicated in
the judgment of the referring
cardiologist, who had access to the
results of the stress echocardio-
gram. A >50% diameter stenosis
at angiography was considered
a signiﬁcant stenosis.
Image analysis. All studies were analyzed by the reviewer at
the time of the study. Perfusion and wall motion (WM)
were both assessed using a 17-segment model (11). In the
CSE arm, the reviewers had access to at least 2 clips of
cardiac cycles obtained at or following peak stress, to
compare side by side with at least 1 cardiac cycle of resting
images in both parasternal and apical windows. These
digitized loops of the 3 apical windows were displayed side
by side for rest and stress comparisons. For RTMCE, both
perfusion and WM were analyzed simultaneously during
the replenishment phase of contrast following brief high
mechanical index impulses as previously described (12), at
baseline and at or following peak stress. For CSE, WM was
analyzed (with or without the aid of enhanced border
delineation with contrast) at baseline and at or following
peak stress. If resting WM abnormalities were present, stress
images were compared with the low dose dobutamine
images (10 mg/kg/min) to assess whether the abnormalities
were ﬁxed or inducible. With treadmill exercise, ischemia
was considered present (instead of infarction) only if hypo-
kinesis (at rest) became akinesis during stress. Studies were
considered abnormal if either ﬁxed or inducible abnormali-
ties were present.
Data and safety monitoring plan. Formal interim moni-
toring of the study was to be done 3 times, after approximately
33%, 66%, and 100% of the expected enrollment with
sequential boundaries determined using The O’Brien-Fleming
spending function (13,14). This was conducted by an inde-
pendent 3-member Data and Safety Monitoring Committee.
Statistical analysis. The primary outcome was event-free
survival (EFS), deﬁned as the time to death, nonfatal MI,
or revascularization. Nonfatal MI was deﬁned as a presen-
tation with chest discomfort or shortness of breath associ-
ated with a serial troponin elevation or ST segment elevation
in 2 contiguous leads. The anticipated total number of
subjects to be enrolled was 3,000, as it was pre-determined
that this sample size would achieve 90% power to detect
a hazard rate of 0.66 when the proportion who are alive and
free of nonfatal MI are 0.90 and 0.93 using a 2-sided
log-rank test. Patient characteristics were descriptively
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tests, or t tests as appropriate. In order to determine what
effect revascularization had on other outcomes, it was
analyzed not only as a separate endpoint, but also as a time-
dependent covariate using only death and nonfatal MI as
endpoints. Survival distributions were estimated following
the method of Kaplan and Meier and compared using the
log-rank test. Cox proportional hazards regression was
conducted to look for univariate predictors of deathþnonfatal
MI. Most of the variables included in the multivariate analysis
were highly correlated, so a backward selected model was also
performed, with an alpha of 0.10 and forcing techniques to
stay in the model.
Results
As required by our Data Safety and Monitoring Board, we
performed an interim analysis after enrollment of 66% of the
patients (2,063 total patients), which indicated the outcome
of patients undergoing CSE versus RTMCE would not be
different for death or nonfatal MI, but would be different
for the combined endpoint of death, nonfatal MI, and
revascularization.
Table 1 presents the demographic data of the patients
included in the study. Patients in each group were similar
with respect to age, gender, prevalence of hypertension,
diabetes, and smoking. There was a slight, but signiﬁcant,
1% higher ejection fraction in the CSE group. Hyperlipid-
emia and use of beta-blockers prior to the stress test were
more common in the RTMCE group, and more patients in
the RTMCE group had prior percutaneous coronary inter-
vention and remote history of MI.
Dobutamine and exercise stress test hemodynamics.
During DSE, the average increase in heart rate and systolic
blood pressure was not different between CSE and
RTMCE groups (Table 2), and there were no differences in
those who failed to attain 85% of their target heart rate.
Patients randomized to RTMCE had a higher incidence of
ventricular arrhythmias and more frequently experienced
chest pain at peak stress (both p values <0.05 compared with
CSE). These arrhythmias were isolated premature atrial or
ventricular contractions, and occurred following the brief
high mechanical index pulse used to clear contrast from the
myocardium. Abnormal EKG responses (>0.1 mV ST-
segment depression) were seen in 22% of abnormal CSE
studies, 28% of abnormal RTMCE studies, 9.6% of normal
CSE studies, and 8% of normal RTMCE studies.
Effect of contrast use on image interpretation in the CSE
and RTMCE groups. A total of 655 patients (63%) in the
CSE group received contrast to optimize WM detection.
The abnormal rate in the CSE group was not different in
patients that received contrast (22% abnormal) versus those
that did not (21% abnormal). Of the 310 abnormal
RTMCE studies, 31 (10%) were abnormal for perfusion
only (WM normal), while the remainder were read as both
abnormal WM and perfusion.The number of patients who had resting WM abnor-
malities was higher in the RTMCE group (13%) compared
with the CSE group (9%; p ¼ 0.004). The resting WM
abnormality in the RTMCE was accompanied by a resting
perfusion defect in 110 patients (75%), which aided in
delineating a subendocardial resting WM abnormality.
Patients who randomized to RTMCE were more likely
to have abnormal stress studies (30% vs. 22% for CSE;
p < 0.001). The pattern of abnormality (single- vs. multi-
vessel territory) was also more likely to be multivessel in the
patients randomized to RTMCE (39% vs. 26% of CSE
studies; p < 0.001).
Angiographic and revascularization outcomes of CSE
versus RTMCE. A total of 145 of the 310 patients (47%)
with abnormal RTMCE, and 81 of 226 abnormal CSE
studies (36%), proceeded to heart catheterization following
abnormal studies. Proceeding to angiography after an
abnormal CSE or RTMCE was not a predictor of death or
nonfatal MI in these patients. Coronary angiography
demonstrated at least 1 >50% obstructive lesion in 1 of the
3 major epicardial vessels in 112 of the RTMCE cases
(positive predictive value 77%) and 59 of the CSE cases
(positive predictive value 73%). However, the number of
revascularizations was more frequent following an abnormal
RTMCE study (26% of all abnormal studies) than following
an abnormal CSE study (15% of all abnormal studies;
p < 0.001 compared with RTMCE). Of the 81 revascu-
larizations following an abnormal RTMCE, 55 were
percutaneous revascularizations, and 26 were coronary
bypass procedures. Of the 33 revascularizations following an
abnormal CSE, 21 were percutaneous and 12 were coronary
bypass procedures.
Predictive value of CSE versus RTMCE. Figure 1
demonstrates the consolidated standards and reporting
trials diagram, which includes the outcomes for the patients
randomized to CSE or RTMCE. Of the 2,063 patients
enrolled on the study, 2,014 have follow-up data. There
were 84 (4.1%) deaths, 20 (1%) nonfatal MIs, and 142
revascularizations (7.0%) over the follow-up period. The
range of troponin elevations in the nonfatal MI patients was
0.12 to 12.87 ng/ml. Of the 142 patients that were revas-
cularized, 6 (4.1%) subsequently died and 4 (2.7%) had an
MI, and thus the death/nonfatal MI rate in the revascular-
ized group alone was 10 of 142 (7.0%).
There were 1,979 alive at last contact with a median
follow-up of 2.6 years (range 0 to 4.3 years). Overall, the
event rate for death or nonfatal MI was 104 (5.2%) of the
2,014 patients with follow-up data. As shown in Figure 2,
death and nonfatal MI rates were signiﬁcantly higher in
patients with abnormal studies by CSE or RTMCE when
compared with normal studies. There was no difference in
death/nonfatal MI rates in the RTMCE group in those
with perfusion defects only (6.5%) versus those with both
perfusion defects and wall motion abnormalities (7.2%).
When considering the combined endpoint of death,
nonfatal MI, and subsequent revascularization, the predictive
Table 1 Baseline Characteristics All Patients (n ¼ 2,063)
Total
(N ¼ 2,063)
CSE
(n ¼ 1,035)
RTMCE
(n ¼ 1,028) p Value
Age, yrs 59.6  12.5 59.4  12.8 59.8  12.2 0.43
Sex
Female 1,069 (52%) 544 (53%) 525 (51%) 0.50
Male 994 (48%) 491 (47%) 503 (49%)
Family history of CAD
No 1,375 (67%) 691 (67%) 684 (67%) 0.91
Yes 688 (33%) 344 (33%) 344 (33%)
Smoking status
Current 469 (23%) 230 (22%) 239 (23%) 0.84
Former 243 (12%) 124 (12%) 119 (12%)
Never 1,351 (65%) 681 (66%) 670 (65%)
Hyperlipidemia
No 951 (46%) 506 (49%) 445 (43%) 0.011
Yes 1,112 (54%) 529 (51%) 583 (57%)
Diabetes
No 1,530 (74%) 773 (75%) 757 (74%) 0.59
Yes 533 (26%) 262 (25%) 271 (26%)
HTN
No 795 (39%) 407 (39%) 388 (38%) 0.46
Yes 1,268 (61%) 628 (61%) 640 (62%)
Previous PTCA
No 1,822 (88%) 936 (90%) 886 (86%) 0.0027
Yes 241 (12%) 99 (10%) 142 (14%)
Previous CABG
No 1,901 (92%) 956 (92%) 945 (92%) 0.71
Yes 162 (8%) 79 (8%) 83 (8%)
Previous MI
No 1,871 (91%) 951 (92%) 920 (89%) 0.062
Yes 192 (9%) 84 (8%) 108 (11%)
Ejection fraction 59.4  9.2 60.2  9.0 58.6  9.3 <0.001
Antiplatelet (clopidogrel)
No 1,945 (94%) 982 (95%) 963 (94%) 0.24
Yes 118 (6%) 53 (5%) 65 (6%)
Beta-blockers
No 1,230 (60%) 641 (62%) 589 (57%) 0.032
Yes 833 (40%) 394 (38%) 439 (43%)
ACE inhibitors or ARB
No 1,454 (70%) 728 (70%) 726 (71%) 0.89
Yes 609 (30%) 307 (30%) 302 (29%)
Aspirin
No 1,314 (64%) 669 (65%) 645 (63%) 0.37
Yes 749 (36%) 366 (35%) 383 (37%)
Test result
Normal result 1,518 (74%) 803 (78%) 715 (69%) <0.001
Abnormal result 536 (26%) 226 (22%) 310 (30%)
Incomplete test 9 (0.4%) 6 (0.6%) 3 (0.3%)
More experienced reviewer
Yes 1,257 (61%) 618 (60%) 639 (62%) 0.25
No 806 (39%) 417 (40%) 389 (38%)
Values are mean  SD or n (%).
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin receptor blockers; CABG ¼ coronary artery bypass grafting; CAD ¼ coronary
artery disease; CSE ¼ conventional stress echocardiography; HTN ¼ hypertension; MI ¼ myocardial infarction; PTCA ¼ percutaneous transluminal
coronary angioplasty; RTMCE ¼ real-time myocardial contrast echocardiography.
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2449value of a negative CSE and negative RTMCE was the
same, but this combined endpoint was signiﬁcantly higher
in patients with an abnormal RTMCE (Fig. 3). Most ofthese revascularizations (60 following RTMCE and 21
following CSE) were within 90 days of the stress echo-
cardiogram. Three-year EFS (death and nonfatal MI only),
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2450when using revascularization as a time-dependent covariate,
was 90.0% after an abnormal RTMCE, and 91.2 % after
an abnormal CSE (not signiﬁcant), and negative studies in
this context had similar 3-year EFS (96.2% following
a negative RTMCE and 95.2% following a negative CSE).
In patients with prior CAD, there were no difference in
death, nonfatal MI, or subsequent revascularization rates
following normal CSE or RTMCE studies, but these rates
were signiﬁcantly higher following abnormal RTMCE
studies compared with abnormal CSE studies (p ¼ 0.026).
In patients with no prior CAD, these rates also trended
higher following abnormal RTMCE studies (p ¼ 0.11).
Death or nonfatal MI following abnormal CSE or
RTMCE studies were signiﬁcantly higher when the expe-
rienced reviewer (R1) read a study as abnormal versus
normal, but were not signiﬁcantly different with less expe-
rienced R2 reviewers (Fig. 4). However, when looking at the
combined endpoint of death, nonfatal MI, and subsequent
revascularization; abnormal and normal studies read by R1
versus R2 reviewers had equivalent predictive value.
Univariate and multivariate predictors of death and
nonfatal MI in CSE versus RTMCE groups. When
combining CSE and RTMCE patients, the univariate
predictors of death or nonfatal MI included test result, prior
revascularization, and presence of a resting wall motion
abnormality (Table 3). Online Table 1 for shows the conﬁ-
dence intervals. A resting WM abnormality was the only
multivariate predictor of events in all patients. Overall, the
3-year event rates were 7.6% in the patients who had
a multivessel pattern of abnormality (82% of which were in
the RTMCE group), 4.2% in patients with a single-vessel
distribution abnormality (79% of which were in the CSE
group) and 4.2% in the normal studies (p¼ 0.029 comparing
multivessel pattern to normal or single-vessel pattern).
In the CSE patients alone, there were no univariate or
multivariate predictors of death or nonfatal MI (Table 4).
See Online Tables 2A and 2B for conﬁdence intervals. This
model included age, prior revascularization, clinical risk
factors, presence of a resting WM abnormality, test result,
and extent of abnormal result. In patients randomized to
RTMCE, only the presence of a resting wall motion
abnormality was a signiﬁcant univariate and multivariate
predictor of death or nonfatal MI (Fig. 5). When the CSE
patients that received contrast and those that did not were
analyzed separately, resting WM abnormalities were still not
predictive of death or nonfatal MI in either group.
Discussion
This is the ﬁrst prospective randomized trial to examine
the clinical outcome of patients after 2 different imaging
approaches for pharmacologic or exercise stress. Retrospec-
tive studies have shown that perfusion information obtained
during demand stress improves the predictive value of
DSE for predicting death and nonfatal MI (4,15). Unlike
retrospective studies examining the predictive value of 1
Figure 1 Consolidated Reporting Diagram
The consolidated standards and reporting trials diagram showing the number of patients referred to the University of Nebraska Echocardiography Laboratory during the
study period, and those who consented to participate. Their subsequent randomized assignments, and outcomes, are shown. CSE ¼ conventional stress echocardiography;
DSE ¼ dobutamine stress echocardiography; ESE ¼ exercise stress echocardiography; RTMCE ¼ real-time myocardial contrast echocardiography
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2451imaging modality, the current study examined the value of
2 optimized imaging approaches in predicting patient
outcome. This allows one to examine both the ability of the
test to identify those who will eventually need revasculari-
zation, as well as predict death or nonfatal MI. In this
context, death, nonfatal MI, and revascularization numbers
were signiﬁcantly higher following an abnormal RTMCE
versus abnormal CSE study.
Previous retrospective studies examining the predictive
value of 1 particular imaging technique (stress echo or stress
radionuclide imaging) have had difﬁculties in assessing the
predictive value of abnormal (or positive) studies, because
revascularizations occurring after the stress study resulted in
either patient exclusion or censoring at the time of the
revascularization (4–6,16). However, radionuclide stress
perfusion studies have demonstrated that subsequent revas-
cularization after a stress test signiﬁcantly impacts the rate of
death or nonfatal MI, especially as the extent of inducible
ischemia increases (17,18). In the current study, theRTMCE arm had a higher abnormalcy rate and a higher
frequency of inducible ischemia in a multi-vessel pattern.
This may have led to signiﬁcantly higher revascularization
rates following angiography in RTMCE patients, despite
similar positive predictive values in detecting a coronary
stenosis. Therefore, the higher number of abnormal studies
in the RTMCE group may have helped in identifying
patients most likely to beneﬁt prognostically from revascu-
larization, and explain the similar death or nonfatal MI
rates following abnormal CSE versus RTMCE studies.
These differences may have also been found if quality of life
measures were assessed in the different patient populations.
Conversely, a negative test (CSE or RTMCE) in predict-
ing hard events was excellent in this intermediate risk patient
population, with 3-year event rates of<5%, similar to previous
studies (4,5). Revascularizations weremuch less likely to occur
in these groups,with a death, nonfatalMI, or revascularization
rate of <2.5% per year. Because revascularizations in the
setting of a negative study would most likely be for acute
Figure 2 Overall Event-Free Survival
Event-free survival (death or nonfatal myocardial infarction [MI]) in patients with an
abnormal stress echo (conventional stress echocardiography [CSE] or real-time
myocardial contrast echocardiography [RTMCE]) versus those with a normal result.
Figure 3 Differences in Event-Free Survival for Primary Endpoint
Event-free survival (death, nonfatal MI, or subsequent revascularization) in those with a n
exam (B). Abbreviations as in Figure 2.
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2452coronary syndrome or medically refractory symptoms,
a negative study by either imaging technique appears to
identify a patient at much lower risk for this clinical scenario.
Although one would assume that CSE should be better
for detecting resting WM abnormalities due to the higher
frame rate to detect tardokinesis (19), it was a resting WM
abnormality detected by RTMCE that was the only
signiﬁcant predictor of death or nonfatal MI in the
univariate and multivariate analyses. One explanation for
this may be the potential for RTMCE to better identify
a critical resting stenosis. When such a stenosis is present,
subendocardial wall thickening is affected more than sub-
epicardial wall thickening, and blood ﬂow is reduced only in
the subendocardium (20). Therefore, the resultant sub-
endocardial perfusion defect (which could only be visualized
when using RTMCE) may have improved the delineation
of a subendocardial wall motion abnormality. Because CSE
can only analyze transmural wall thickening, it would have
more difﬁculty in detecting a wall thickening abnormality
conﬁned to the subendocardium. In this setting, resting wall
motion abnormalities combined with resting perfusion
defects with contrast echocardiography have been shown to
identify the highest risk subgroup of patients presenting
with potential acute coronary syndromes, even within 12 h
of the episode of chest pain (21). Patients presenting to
the emergency department with chest pain and negative or
equivocal troponin values were included in our study, andormal CSE and RTMCE exam (A), and in those with an abnormal CSE and RTMCE
Figure 4 Reviewer Experience and Outcome
EFS (death or nonfatal MI) in patients with an abnormal versus normal stress echo based on reviewer experience. R1 (Fig. 3A) is a reviewer with experience in reviewing over
1,000 RTMCE and CSE studies. R2 are the reviewers who had Level 3 training in echocardiography, and who had interpreted over 100 contrast studies for left ventricular
opaciﬁcation and for perfusion imaging. Abbreviations as in Figure 2.
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2453resting RTMCE may have aided in detecting a high-risk
subgroup of patients in this category.
Study limitations. Reviewer experience plays a role in the
evaluation of contrast-enhanced images, independent ofTable 3 Univariate and Multivariate Models of EFS (DeathþMI)
Variable Univariate
Full
Multivariate
Backward
Selected
Model
Technique (RTMCE vs. CSE) 0.64 0.95 0.78
Age >70 vs. 70 yrs 0.071 0.088 0.087
EF <50% vs. 50% 0.055 0.70
Prior revascularization
(PTCA or CABG)
0.061 0.61
DM 0.19 0.24
Hyperlipidemia 0.82
Antiplatelet (clopidogrel) 0.90
Aspirin 0.78
Resting wall motion
abnormality (yes vs. no)
0.004 0.13 0.005
ECHO result (abnormal vs.
normal)
0.040
More experienced reviewer
(yes vs. no)
0.36
Extent of abnormality
(2 territories vs. normal/
single vessel)
0.029 0.81
Revascularization following
stress echo
0.17 0.52
Values are p values.
DM ¼ diabetes mellitus; ECHO ¼ echocardiography; EF ¼ ejection fraction; EFS ¼ event-free
survival; other abbreviations as in Table 1.whether it is being utilized for CSE or RTMCE. Although
an abnormal study read by an experienced versus less expe-
rienced reviewer was equivalent in predicting subsequent
revascularization, death, or nonfatal MI, only the experi-
enced reviewer was able to predict death or nonfatal MI
when revascularization was considered as a time-dependent
covariate. This was true for both RTMCE and CSE
studies, and emphasizes the critical role of formal contrast
training in both of these imaging approaches. Unfortunately,
no formal guidelines exist for contrast echo training within
current American College of Cardiology/American Heart
Association Guidelines(8), while at least 300 performed and
interpreted studies are required for Level 2 training in other
established imaging techniques. Based on the differences in
contrast experience between R1 versus R2, it would appear
that a Level 2 training equivalent of 300 contrast cases would
be needed to improve an interpreter’s ability to predict
outcome.
The RTMCE group had a higher proportion of patients
with prior MI and prior percutaneous intervention. This may
indicate some recruitment bias toward patients with higher
pre-test probability when certain interpreters were reading,
and patients with more advanced disease being randomized
to RTMCE. Therefore, it is reasonable to assume from our
study that the prevalence of more advanced disease was
higher in the RTMCE patients. RTMCE identiﬁed this
more advanced disease resulting in higher revascularization
numbers, which may have equalized the death and nonfatal
MI rates following abnormal studies in the 2 groups.
Table 4 Univariate and Multivariate Models of EFS (DeathþMI)
Variable
CSE Patients RTMCE Patients
Univariate
Full
Multivariate
Backward
Selected Model Univariate
Full
Multivariate
Backward
Selected Model
Age >70 versus 70 yrs 0.25 0.16 0.22
EF <50% versus 50% 0.31 0.11 0.85
Prior revascularization (PTCA or CABG) 0.64 0.044 0.45
DM 0.061 0.098 0.061 0.99
Hyperlipidemia 0.58 0.84
Antiplatelet (clopidogrel) 0.67 0.81
Aspirin 0.28 0.17 0.73
Resting wall motion abnormality (yes vs. no) 0.67 0.001 0.014 0.001
Echo result (abnormal vs. normal) 0.17 0.48 0.15
More experienced reviewer (yes vs. no) 0.97 0.19 0.13
Extent of abnormality 2 territories vs. normal/single vessel 0.14 0.50 0.11 0.73
Revascularization following stress echo 0.48 0.25
Values are p values.
Abbreviations as in Tables 1 and 3.
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2454Because this study was multireader but not multicenter,
institutional biases may have played a role in outcome.
For example, contrast use for conventional stress echo was
higher at our institution than what is being used in the
general population. Because contrast use has been shown to
improve the diagnostic quality of a conventional stress
echocardiogram (22), its higher use in the CSE arm may
have improved both the detection and exclusion of ischemia.
In institutions where contrast use during CSE is less, the
predictive value of the test may not be the same.
Conclusions/Clinical implications. Therefore, in this
prospective clinical comparison, both RTMCE and CSEFigure 5 Outcome With RWMA
EFS (death or nonfatal MI) in patients with resting wall motion abnormalities (RWMA) detec
abnormality predictive of death or nonfatal MI. Abbreviations as in Figure 2.appear to be excellent at risk stratifying patients at inter-
mediate risk for CAD. When performed properly, RTMCE
identiﬁes more patients with CAD and extensive ischemia,
and those more likely to require revascularization. A resting
WM abnormality detected with RTMCE is highly predic-
tive of adverse outcomes, while it is not predictive of
outcome with CSE. Therefore, although the prognostic
values of RTMCE and CSE are similar when revasculari-
zation is considered as a time dependent covariate, stress
RTMCE should be the preferred technique for detecting
those who may need revascularization, and RTMCE is
better for detecting a resting WMA (wall motionted by RTMCE versus CSE. Note that only in RTMCE patients was a resting wall motion
JACC Vol. 61, No. 24, 2013 Porter et al.
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2455abnormalities) that will impact outcome. Revascularization
following an abnormal RTMCE may have altered the
clinical course of the disease with respect to subsequent
death or nonfatal MI. Further studies will be required to
verify this important possibility.
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